Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 28;60(4):552.
doi: 10.3390/medicina60040552.

Paraneoplastic Syndromes in Hepatocellular Carcinoma, Epidemiology, and Survival: A Retrospective Seven Years Study

Calin Burciu  1   2   3 , Roxana Sirli  1   2 , Renata Bende  1   2 , Deiana Vuletici  1   2 , Bogdan Miutescu  1   2 , Tudor Moga  1   2 , Felix Bende  1   2 , Alina Popescu  1   2 , Ioan Sporea  1   2 , Oana Koppandi  3 , Eftimie Miutescu  3 , Dana Iovanescu  3 , Mirela Danila  1   2
Affiliations

Paraneoplastic Syndromes in Hepatocellular Carcinoma, Epidemiology, and Survival: A Retrospective Seven Years Study

Calin Burciu et al. Medicina (Kaunas). .

Abstract

Background and Objectives: Liver cancer poses a significant global health threat, ranking among the top three causes of cancer-related deaths. Patients with hepatocellular carcinoma (HCC) often present with symptoms associated with neoplasms or unusual clinical features such as paraneoplastic syndromes (PNS), including hypoglycemia, hypercholesterolemia, thrombocytosis, and erythrocytosis. Our study aimed to investigate the prevalence, clinical characteristics, and survival outcomes associated with PNS in HCC patients and assess each PNS's impact on patient survival. Materials and Methods: We conducted a retrospective analysis of PNS clinical features and survival among consecutive HCC patients diagnosed at our department over seven years, comparing them with HCC patients without PNS. The study involved a retrospective data evaluation from 378 patients diagnosed with HCC between January 2016 and October 2023. Results: We obtained a PNS prevalence of 25.7%, with paraneoplastic hypercholesterolemia at 10.9%, hypoglycemia at 6.9%, erythrocytosis at 4.5%, and thrombocytosis at 3.4%. Patients with PNS tended to be younger and predominantly male. Multivariate analysis revealed a strong correlation between PNS and levels of alpha-fetoprotein and tumor size, with diabetes also showing a significant statistical association (p < 0.05). Subgroup analysis based on specific paraneoplastic syndromes demonstrated shorter survival in patients with PNS, albeit without significant statistical differences, except for hypoglycemia (p < 0.0001). Matched analysis indicated a shorter survival rate for patients with PNS, although no significant statistical differences were observed. Conclusions: PNS are frequently observed in HCC cases and are associated with unfavorable prognoses and decreased survival rates due to their correlation with increased tumor burdens. However, they do not independently predict poor survival. The impact of individual PNS on HCC prognosis varies.

Keywords: hepatocellular carcinoma; paraneoplastic syndromes; survival.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Kaplan–Meier survival curve according to the presence of paraneoplastic syndromes: (a) hypercholesterolemia; (b) erythrocytosis; (c) hypoglycemia; (d) thrombocytosis.
See this image and copyright information in PMC

References

    1. Rumgay H., Arnold M., Ferlay J., Lesi O., Cabasag C.J., Vignat J., Laversanne M., McGlynn K.A., Soerjomataram I. Global burden of primary liver cancer in 2020 and predictions to 2040. J. Hepatol. 2022;77:1598–1606. doi: 10.1016/j.jhep.2022.08.021. - DOI - PMC - PubMed
    1. Rumgay H., Ferlay J., de Martel C., Georges D., Ibrahim A.S., Zheng R., Wei W., Lemmens V.E.P.P., Soerjomataram I. Global, regional and national burden of primary liver cancer by subtype. Eur. J. Cancer. 2022;161:108–118. doi: 10.1016/j.ejca.2021.11.023. - DOI - PubMed
    1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 2005;55:74–108. doi: 10.3322/canjclin.55.2.74. - DOI - PubMed
    1. Sangiovanni A., Prati G.M., Fasani P., Ronchi G., Romeo R., Manini M., Del Ninno E., Morabito A., Colombo M. The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients. Hepatology. 2006;43:1303–1310. doi: 10.1002/hep.21176. - DOI - PubMed
    1. Luo J.C., Hwang S.J., Wu J.C., Li C.P., Hsiao L.T., Lai C.R., Chiang J.H., Lui W.Y., Chang F.Y., Lee S.D. Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan. Cancer. 1999;86:799–804. doi: 10.1002/(SICI)1097-0142(19990901)86:5<799::AID-CNCR15>3.0.CO;2-#. - DOI - PubMed

MeSH terms